Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine.

DeRose YS, Gligorich KM, Wang G, Georgelas A, Bowman P, Courdy SJ, Welm AL, Welm BE.

Curr Protoc Pharmacol. 2013 Mar;Chapter 14:Unit14.23. doi: 10.1002/0471141755.ph1423s60.

2.
3.

Overview of Genetically Engineered Mouse Models of Breast Cancer Used in Translational Biology and Drug Development.

Greenow KR, Smalley MJ.

Curr Protoc Pharmacol. 2015 Sep 1;70:14.36.1-14. doi: 10.1002/0471141755.ph1436s70. Review.

PMID:
26331886
4.

Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models.

Bergamaschi A, Hjortland GO, Triulzi T, Sørlie T, Johnsen H, Ree AH, Russnes HG, Tronnes S, Maelandsmo GM, Fodstad O, Borresen-Dale AL, Engebraaten O.

Mol Oncol. 2009 Dec;3(5-6):469-82. doi: 10.1016/j.molonc.2009.07.003. Epub 2009 Aug 4.

5.

The nude mouse as an in vivo model for human breast cancer invasion and metastasis.

Brünner N, Boysen B, Rømer J, Spang-Thomsen M.

Breast Cancer Res Treat. 1993;24(3):257-64.

PMID:
8435480
6.

Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy.

Norum JH, Andersen K, Sørlie T.

Br J Surg. 2014 Jul;101(8):925-38. doi: 10.1002/bjs.9562. Epub 2014 May 21. Review.

PMID:
24849143
7.

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes.

DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, Factor R, Matsen C, Milash BA, Nelson E, Neumayer L, Randall RL, Stijleman IJ, Welm BE, Welm AL.

Nat Med. 2011 Oct 23;17(11):1514-20. doi: 10.1038/nm.2454.

8.

Human tissue-specific microenvironment: an essential requirement for mouse models of breast cancer.

Xia TS, Wang J, Yin H, Ding Q, Zhang YF, Yang HW, Liu XA, Dong M, Du Q, Ling LJ, Zha XM, Fu W, Wang S.

Oncol Rep. 2010 Jul;24(1):203-11.

PMID:
20514463
9.

Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue.

Monsma DJ, Monks NR, Cherba DM, Dylewski D, Eugster E, Jahn H, Srikanth S, Scott SB, Richardson PJ, Everts RE, Ishkin A, Nikolsky Y, Resau JH, Sigler R, Nickoloff BJ, Webb CP.

J Transl Med. 2012 Jun 18;10:125. doi: 10.1186/1479-5876-10-125.

10.

Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.

Amemiya Y, Yang W, Benatar T, Nofech-Mozes S, Yee A, Kahn H, Holloway C, Seth A.

Breast Cancer Res Treat. 2011 Apr;126(2):373-84. doi: 10.1007/s10549-010-0921-0. Epub 2010 May 13.

PMID:
20464481
11.

In vivo xenograft models of breast cancer metastasis.

Valentiner U, Brooks SA, Schumacher U.

Methods Mol Med. 2006;120:479-88.

PMID:
16491620
12.

Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model.

Sharma M, Blackman MR, Sharma MC.

Exp Mol Pathol. 2012 Feb;92(1):175-84. doi: 10.1016/j.yexmp.2011.10.003. Epub 2011 Oct 25.

PMID:
22044461
13.

A mouse model of human breast cancer metastasis to human bone.

Kuperwasser C, Dessain S, Bierbaum BE, Garnet D, Sperandio K, Gauvin GP, Naber SP, Weinberg RA, Rosenblatt M.

Cancer Res. 2005 Jul 15;65(14):6130-8.

14.
15.

Endocrine therapy of human breast cancer grown in nude mice.

Brünner N, Osborne CK, Spang-Thomsen M.

Breast Cancer Res Treat. 1987 Dec;10(3):229-42. Review.

PMID:
3328985
16.

Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.

Lee HW, Lee JI, Lee SJ, Cho HJ, Song HJ, Jeong DE, Seo YJ, Shin S, Joung JG, Kwon YJ, Choi YL, Park WY, Lee HM, Seol HJ, Shim YM, Joo KM, Nam DH.

Clin Cancer Res. 2015 Mar 1;21(5):1172-82. doi: 10.1158/1078-0432.CCR-14-1589. Epub 2014 Dec 30.

17.

A metastatic orthotopic-transplant nude-mouse model of human patient breast cancer.

Fu X, Le P, Hoffman RM.

Anticancer Res. 1993 Jul-Aug;13(4):901-4.

PMID:
8352558
18.
20.

Supplemental Content

Support Center